KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) Net Income towards Common Stockholders (2016 - 2025)

Tenet Healthcare's Net Income towards Common Stockholders history spans 17 years, with the latest figure at $371.0 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 16.67% year-over-year to $371.0 million; the TTM value through Dec 2025 reached $1.4 billion, down 56.03%, while the annual FY2025 figure was $1.4 billion, 56.03% down from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $371.0 million at Tenet Healthcare, up from $342.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $2.2 billion in Q1 2024 and bottomed at -$1.0 million in Q2 2021.
  • The 5-year median for Net Income towards Common Stockholders is $244.0 million (2023), against an average of $305.2 million.
  • The largest annual shift saw Net Income towards Common Stockholders tumbled 101.14% in 2021 before it soared 14200.0% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $249.0 million in 2021, then crashed by 59.04% to $102.0 million in 2022, then surged by 139.22% to $244.0 million in 2023, then skyrocketed by 30.33% to $318.0 million in 2024, then increased by 16.67% to $371.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Net Income towards Common Stockholders are $371.0 million (Q4 2025), $342.0 million (Q3 2025), and $288.0 million (Q2 2025).